Тёмный

Cancer Care in the Era of Genomics and Proteomics with Patrick Soon-Shiong, MD 

University of California Television (UCTV)
Подписаться 1,3 млн
Просмотров 27 тыс.
50% 1

Опубликовано:

 

21 окт 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 26   
@rodsol7208
@rodsol7208 3 года назад
This guy is very impressive and I am proud that he is a South African
@вяитмии
@вяитмии 6 лет назад
See, THESE are the kind of ppl that deserve to be paid millions of dollars! Not your everyday entertainer we see so often in the media...
@AvidFlyer1928
@AvidFlyer1928 9 лет назад
Dr Soon-Shiong has discovered a unique approach though Scientific methodology in diagnosing and curing cancer therefore has greatly contributed in alleviating the humankind of suffering for generations to come.
@momwithdaughters
@momwithdaughters 2 года назад
Ddxd, f, xse
@philtrem
@philtrem 10 лет назад
Totally mindblown.
@azbieberfever
@azbieberfever 10 лет назад
He is working with my Company for Pediatric disease research. Very amazing to me, I hope the cure is in my lifetime.
@aoifewest
@aoifewest 10 лет назад
Exciting , even more when I watched this today just after having talked to my human genom teacher about why the DNA was the sole research target eventhough DNA , cell signaling and immun system is all proteins... Now I am really exccited to study more according my own intuitions.
@SamakayiKatambo
@SamakayiKatambo 4 года назад
I see a Nobel prize coming his way
@fundip43
@fundip43 10 лет назад
Great introduction but to get to the lecture 8:00
@bencyber8595
@bencyber8595 4 года назад
ok. , tnx uniform
@ricpitt1
@ricpitt1 7 лет назад
ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("ProMetic" or the "Corporation") announced today that California Capital Equity, LLC, has exercised 44,791,488 share purchase warrants at a price of $0.47 per share for total proceeds of $21,051,999.36 to the Corporation. "Our increased equity position in ProMetic represents a long term and strategic investment for us", said Dr. Patrick Soon-Shiong, Chief Executive Officer of California Capital Equity, LLC. "ProMetic has robust proprietary therapeutic platforms, promising growth potential and several plasma derived therapeutics expected to reach commercialization stages, starting in 2017 with plasminogen. We, through other investment vehicles, also have an on-going partnership with ProMetic in relation to IVIG and anticipate further collaborations going forward", added Dr. Soon-Shiong. Commenting on the exercise of warrants by California Capital Equity, LLC., Mr. Pierre Laurin, President and Chief Executive Officer of ProMetic Life Sciences Inc., said: "We are delighted to see our long-standing relationship with Dr. Soon-Shiong, which dates back to 2008, continue to evolve as we prepare for our first commercial launch in 2017".
@enricobellomo1533
@enricobellomo1533 9 лет назад
They can use a new podium
@sebastianaguiarbrunemeier9192
@sebastianaguiarbrunemeier9192 7 лет назад
Looking past his name-dropping and egotism, he makes an original point: the medical system should be paid based on patient outcomes, not services rendered per se.
@pattomongin1542
@pattomongin1542 6 лет назад
e
Далее
Борщ в стиле высокой кухни!
00:57
Наши дети захватили кухню!
00:59
Просмотров 157 тыс.
Fake Referee Whistle Moments 😅
00:38
Просмотров 4,9 млн
Master's Commencement Speaker: Patrick Soon Shiong
12:59
Борщ в стиле высокой кухни!
00:57